BiotechMashup

(International Osteoporosis Foundation) An article just published in the journal Osteoporosis International introduces a validated new model that can be used to forecast the current and future burden of postmenopausal osteoporosis in different national settings.

(International Osteoporosis Foundation) An international group of researchers has today presented research at the European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF) that compares the prevalence and location of fractures in obese (BMI≥30 kg/m2) and non-obese postmenopausal women and examines specific risk factors for fracture. The research demonstrates that obese postmenopausal women are almost as likely to fracture as non-obese women, and that poor mobility and increased risk of falls may play an important role.

(International Osteoporosis Foundation) A new audit report issued today by the International Osteoporosis Foundation shows that osteoporosis is a serious and growing problem throughout the Middle East and parts of Africa. Gathering data from 17 countries in the region as well as Turkey, "The Middle East & Africa Regional Audit" is a landmark report examining epidemiology, costs and burden in individual countries as well as collectively across the region.

Italian postmenopausal women who have a low calcium intake show a higher risk of developing both osteoporosis and hypertension (a chronic medical condition in which arterial blood pressure is elevated) than those who consume higher levels of calcium, according to new research.

(International Osteoporosis Foundation) A new report by the International Osteoporosis Foundation in collaboration with the European Federation of Pharmaceutical Industry Associations reveals that the burden of fractures in Europe has been vastly underestimated. The report concludes that in Europe's five largest countries and Sweden alone, an estimated 2.5 million new fragility fractures occurred in 2010; fractures result in more costs and disability than many other common chronic diseases

by Yang Wang, Ling Li, Benjamin T. Moore, Xian-Hao Peng, Xiang Fang, Joan M. Lappe, Robert R. Recker, Peng Xiao

by Yang Wang, Ling Li, Benjamin T. Moore, Xian-Hao Peng, Xiang Fang, Joan M. Lappe, Robert R. Recker, Peng Xiao

Low cost osteoporosis drugs are strictly rationed for the under-75s, and UK physicians hampered by restrictive guidelines, according to findings which appear today in the journal Therapeutic Advances in Musculoskeletal Disease, published by SAGE. A leading Cambridge University bone health expert has outlined flaws in NICE osteoporosis treatment guidance, which limits options for many postmenopausal women in the under-75 age bracket.

(International Osteoporosis Foundation) New report reviewing data from 6 major European countries finds large gap between the number of people that are treated for osteoporosis compared to the number that are eligible for treatment based on fracture risk. Low adherence to medication compounds the treatment gap. The report found that 13 percent of the projected increase in fractures by year 2025 could be avoided cost-effectively with increased uptake of osteoporosis treatments.